Results 131 to 140 of about 262,646 (192)

Assessing treatment effect heterogeneity in the presence of missing effect modifier data in cluster-randomized trials. [PDF]

Stat Methods Med Res
Blette BS, Halpern SD, Li F, Harhay MO.
europepmc   +1 more source

Methods for the estimation of direct and indirect vaccination effects by combining data from individual- and cluster-randomized trials. [PDF]

Stat Med
Wang R, Cen M, Huang Y, Qian G, Dean NE, Ellenberg SS, Fleming TR, Lu W, Longini IM.   +8 more
europepmc   +1 more source

Considerations for Subgroup Analyses in Cluster-Randomized Trials Based on Aggregated Individual-Level Predictors. [PDF]

Prev Sci
Williamson BD, Coley RY, Hsu C, McCracken CE, Cook AJ.   +4 more
europepmc   +1 more source

Engagement With Digital Adherence Technologies as Measures of Intervention Fidelity Among Adults With Drug-Susceptible Tuberculosis and Health Care Providers: Descriptive Analysis Using Data From Cluster-Randomized Trials in Five Countries.

JMIR Public Health Surveill
Alacapa J, Tadesse AW, Deyanova N, Dube T, Mganga A, Powers R, van Rest J, Madden N, Efo E, Charalambous S, van Kalmthout K, Jerene D, Fielding K.   +12 more
europepmc   +1 more source

Sample Size Requirements to Test Subgroup-Specific Treatment Effects in Cluster-Randomized Trials. [PDF]

Prev Sci
Wang X, Goldfeld KS, Taljaard M, Li F.
europepmc   +1 more source

Maintaining the validity of inference from linear mixed models in stepped-wedge cluster randomized trials under misspecified random-effects structures. [PDF]

Stat Methods Med Res
Ouyang Y, Taljaard M, Forbes AB, Li F.
europepmc   +1 more source

Stakeholders' experiences of ethical challenges in cluster randomized trials in a limited resource setting: a qualitative analysis. [PDF]

Res Ethics
Mtande TK, Lombard C, Nair G, Rennie S.
europepmc   +1 more source

Adherence to key recommendations for design and analysis of stepped-wedge cluster randomized trials: A review of trials published 2016-2022. [PDF]

Clin Trials
Nevins P, Ryan M, Davis-Plourde K, Ouyang Y, Pereira Macedo JA, Meng C, Tong G, Wang X, Ortiz-Reyes L, Caille A, Li F, Taljaard M.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Cluster Randomized Trials

JAMA, 2015
Sometimes a new treatment is best introduced to an entire group of patients rather than to individual patients. Examples include when the new approach requires procedures be followed by multiple members of a health care team or when the new technique is applied to the environment of care (eg, a method for cleaning a hospital room before it is known ...
Nathan R. Todd, Patrick J. Fowler
  +5 more sources

Cluster-randomized trials

Palliative Medicine, 2002
Cluster-randomized trials represent an important experimental design, supplementing ordinary randomized clinical trials. They are particularly relevant when evaluating interventions at the level of clinic, hospital, district or region. They are necessary when it is not feasible to randomize individual patients, and desirable when there may be ...
P M, Fayers, M S, Jordhøy, S, Kaasa
openaire   +2 more sources